Status:
UNKNOWN
Long-term Outcomes After Different Management Strategies for High-level Cerebral Arteriovenous Malformation
Lead Sponsor:
Beijing Tiantan Hospital
Collaborating Sponsors:
Peking University International Hospital
Conditions:
Arteriovenous Malformation of Brain
Eligibility:
All Genders
1-80 years
Brief Summary
Arteriovenous malformations (AVMs) are complex and rare cerebral vascular dysplasia. The main purpose of treatment is to avoid the neurological impairment caused by hemorrhagic stroke. The Spetzler-Ma...
Detailed Description
Follow-up: In our neurosurgical center, follow-up was conducted for all patients at the first 3-6 months and annually after discharge by clinical visit and telephone interview. Study overview: The po...
Eligibility Criteria
Inclusion
- The diagnosis of AVM was confirmed with digital subtraction angiography (DSA) and/or magnetic resonance imaging(MRI).
- The SM grade was IV and V.
Exclusion
- Patients with multiple AVMs.
- Patients with hereditary hemorrhagic telangiectasia (HHT).
- Patients with missing clinical and imaging data.
Key Trial Info
Start Date :
April 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04136860
Start Date
April 1 2012
End Date
December 1 2024
Last Update
November 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Capital medical university affiliated Beijing Tiantan hospital
Beijing, Beijing Municipality, China, 101100